![Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7148e1-BivalentBooster_IMAGE_22NOV2022_1200x675.jpg?_=65732)
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
![ATAGI statement on the Omicron variant and timing of COVID-19 booster vaccination | Australian Government Department of Health and Aged Care ATAGI statement on the Omicron variant and timing of COVID-19 booster vaccination | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/images/news/2021/12/atagi-statement-on-the-omicron-variant-and-timing-of-covid-19-booster-vaccination.jpeg)
ATAGI statement on the Omicron variant and timing of COVID-19 booster vaccination | Australian Government Department of Health and Aged Care
![COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/372ade5e-5f14-48a9-b960-4b5767839337/gr1_lrg.jpg)
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases
![Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet](https://www.thelancet.com/cms/asset/caf9bf39-ae54-4e4f-a650-c7d3a3b705f9/gr1.jpg)
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
![OHSU News on X: "COVID-19 booster shot timing. Two of the widely available COVID-19 vaccines, from Moderna and from Pfizer, are designed to be most effective after two doses. But what if OHSU News on X: "COVID-19 booster shot timing. Two of the widely available COVID-19 vaccines, from Moderna and from Pfizer, are designed to be most effective after two doses. But what if](https://pbs.twimg.com/media/Ex5LuSGWEAIP7SJ.jpg)